ST
Stenocare A/S
STENO.CO · CPH
0.92 kr +2.00% (+0.02 kr)
1M -4.26%
Market Cap 40.6M kr
P/E Ratio -
Div. Yield -
ROE 15.49%
Piotroski F-Score Weak
2/9Valuation
20 /100
Expensive EV/EBITDA 197.43x
P/B 4.73x
P/S 3.52x
Growth
72 /100
Growing Rev. growth 16.07%
Book val. growth 26.79%
EPS growth N/A
Profitability
0 /100
Weak Gross margin 5.53%
FCF margin 11.00%
Net margin 9.83%
Quality
12 /100
Poor ROIC 6.62%
Asset turnover 0.93x
ROE 15.49%
Debt
76 /100
Low Debt/Equity 0.12x
Net debt/EBITDA -3.42x
Current ratio 1.47x
Stability
32 /100
Unstable Beta 0.50x
Profitable years 0
Rev. volatility 140.82%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o STENO.CO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Thomas Skovlund Schnegelsberg
Employees
4
Headquarters
Randers